APW
CYTK icon

Aventura Private Wealth’s Cytokinetics CYTK Stock Holding History

Aventura Private Wealth’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-88
Closed -$3.54K – 796
2025
Q1 		$3.54K Hold
88
– – ﹤0.01% 551
2024
Q4 		$4.14K Buy
+88
New +$4.57K ﹤0.01% 521

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Aventura Private Wealth's CYTK Position: Q2 2025 in Review

Aventura Private Wealth sold out of Cytokinetics (CYTK) in Q2 2025, closing a stake of 88 shares — an estimated $3.54K sold.

Aventura Private Wealth first reported a position in CYTK in Q4 2024 and held it in 2 quarters. The position peaked at $4.14K in Q4 2024. 311 funds tracked by Wall St. Rank hold CYTK as of Q2 2025.

  • Aventura Private Wealth reported no remaining Cytokinetics position as of Q2 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 88 Cytokinetics shares in Q2 2025, an estimated $3.54K.
  • Aventura Private Wealth first reported a position in Cytokinetics in Q4 2024 and held it in 2 quarters.
  • Aventura Private Wealth's Cytokinetics position peaked at $4.14K in Q4 2024.
  • 311 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2025.

Based on Aventura Private Wealth's 13F filing for Q2 2025, filed 7 Jan 2026.